BWAY
Price
$14.65
Change
-$0.26 (-1.74%)
Updated
Sep 26, 12:49 PM (EDT)
Capitalization
279.62M
47 days until earnings call
DXR
Price
$11.89
Change
-$0.09 (-0.75%)
Updated
Sep 26, 12:40 PM (EDT)
Capitalization
59.73M
Interact to see
Advertisement

BWAY vs DXR

Header iconBWAY vs DXR Comparison
Open Charts BWAY vs DXRBanner chart's image
BrainsWay
Price$14.65
Change-$0.26 (-1.74%)
Volume$987
Capitalization279.62M
Daxor
Price$11.89
Change-$0.09 (-0.75%)
Volume$350
Capitalization59.73M
BWAY vs DXR Comparison Chart in %
Loading...
BWAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BWAY vs. DXR commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BWAY is a Buy and DXR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (BWAY: $14.91 vs. DXR: $11.98)
Brand notoriety: BWAY and DXR are both not notable
BWAY represents the Medical/Nursing Services, while DXR is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BWAY: 104% vs. DXR: 14%
Market capitalization -- BWAY: $279.62M vs. DXR: $59.73M
BWAY [@Medical/Nursing Services] is valued at $279.62M. DXR’s [@Pharmaceuticals: Other] market capitalization is $59.73M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $232.02B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $157.06B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.49B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BWAY’s FA Score shows that 0 FA rating(s) are green whileDXR’s FA Score has 1 green FA rating(s).

  • BWAY’s FA Score: 0 green, 5 red.
  • DXR’s FA Score: 1 green, 4 red.
According to our system of comparison, DXR is a better buy in the long-term than BWAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BWAY’s TA Score shows that 3 TA indicator(s) are bullish while DXR’s TA Score has 4 bullish TA indicator(s).

  • BWAY’s TA Score: 3 bullish, 5 bearish.
  • DXR’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, DXR is a better buy in the short-term than BWAY.

Price Growth

BWAY (@Medical/Nursing Services) experienced а -6.58% price change this week, while DXR (@Pharmaceuticals: Other) price change was +5.11% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.15%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +9.32%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.48%. For the same industry, the average monthly price growth was -3.57%, and the average quarterly price growth was +8.48%.

Reported Earning Dates

BWAY is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Medical/Nursing Services (-2.15% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-1.48% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BWAY($280M) has a higher market cap than DXR($59.7M). DXR has higher P/E ratio than BWAY: DXR (74.89) vs BWAY (53.25). BWAY (58.112) and DXR (55.822) have similar YTD gains . DXR has less debt than BWAY: DXR (263K) vs BWAY (6.13M). BWAY has higher revenues than DXR: BWAY (46.1M) vs DXR (3.31M).
BWAYDXRBWAY / DXR
Capitalization280M59.7M469%
EBITDA8.3MN/A-
Gain YTD58.11255.822104%
P/E Ratio53.2574.8971%
Revenue46.1M3.31M1,392%
Total Cash78MN/A-
Total Debt6.13M263K2,331%
FUNDAMENTALS RATINGS
BWAY vs DXR: Fundamental Ratings
BWAY
DXR
OUTLOOK RATING
1..100
8160
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
56100
SMR RATING
1..100
7284
PRICE GROWTH RATING
1..100
4142
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BWAY's Valuation (76) in the Medical Specialties industry is in the same range as DXR (90). This means that BWAY’s stock grew similarly to DXR’s over the last 12 months.

BWAY's Profit vs Risk Rating (56) in the Medical Specialties industry is somewhat better than the same rating for DXR (100). This means that BWAY’s stock grew somewhat faster than DXR’s over the last 12 months.

BWAY's SMR Rating (72) in the Medical Specialties industry is in the same range as DXR (84). This means that BWAY’s stock grew similarly to DXR’s over the last 12 months.

BWAY's Price Growth Rating (41) in the Medical Specialties industry is in the same range as DXR (42). This means that BWAY’s stock grew similarly to DXR’s over the last 12 months.

DXR's P/E Growth Rating (2) in the Medical Specialties industry is significantly better than the same rating for BWAY (100). This means that DXR’s stock grew significantly faster than BWAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BWAYDXR
RSI
ODDS (%)
Bearish Trend 1 day ago
82%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
67%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
70%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
70%
Advances
ODDS (%)
Bullish Trend 17 days ago
84%
Bullish Trend 23 days ago
67%
Declines
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 10 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
BWAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VASO0.120.01
+4.57%
Vaso Corporation
LTSAP19.380.13
+0.66%
Osaic Financial Services, Inc.
LGDTF0.43N/A
+0.36%
Liberty Gold Corp
MFRVF0.32N/A
N/A
Minera Frisco S A B
SKSBF25.35N/A
N/A
Skanska AB

BWAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BWAY has been loosely correlated with STIM. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if BWAY jumps, then STIM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BWAY
1D Price
Change %
BWAY100%
N/A
STIM - BWAY
34%
Loosely correlated
-4.30%
BFLY - BWAY
32%
Poorly correlated
-5.31%
CLPT - BWAY
32%
Poorly correlated
+2.39%
ISRG - BWAY
31%
Poorly correlated
-1.32%
ITGR - BWAY
29%
Poorly correlated
-1.17%
More

DXR and

Correlation & Price change

A.I.dvisor tells us that DXR and IART have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DXR and IART's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DXR
1D Price
Change %
DXR100%
+2.09%
IART - DXR
33%
Poorly correlated
-5.25%
BWAY - DXR
27%
Poorly correlated
N/A
NOTV - DXR
24%
Poorly correlated
-4.23%
QIPT - DXR
23%
Poorly correlated
-1.83%
COO - DXR
20%
Poorly correlated
-2.14%
More